# A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)

> **NCT01081652** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 238 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Micronised Progesterone
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT01081652
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081652, "A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01081652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*